New Key Statistics Module, Z-Score and F-Score
NAS:BOLT Key Ratios
| Market Cap $ M | 19.82 |
| Enterprise Value $ M | -16.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.28 |
| Price/Sales | 2.02 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -1.71 |
| Beneish M-Score | -2.05 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -9.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.22 |
| EV-to-EBITDA | 0.22 |
| PEG | -- |
| Shares Outstanding M | 38.27 |
| Net Margin (%) | -665.56 |
| Operating Margin % | -739.68 |
| Pre-tax Margin (%) | -665.56 |
| Quick Ratio | 3.16 |
| Current Ratio | 3.16 |
| ROA % (ttm) | -45.74 |
| ROE % (ttm) | -64.69 |
| ROIC % (ttm) | -122.47 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.40 |
BOLT Number of Guru Trades
BOLT Volume of Guru Trades
Gurus Latest Trades with NAS:BOLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BOLT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bolt Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:BOLT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers